ACOTEC SCIEN.H. DL-00001 - Asset Resilience Ratio

Latest as of June 2025: 18.64%

ACOTEC SCIEN.H. DL-00001 (7W3) has an Asset Resilience Ratio of 18.64% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ACOTEC SCIEN.H. DL-00001 (7W3) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€340.68 Million
≈ $398.29 Million USD Cash + Short-term Investments

Total Assets

€1.83 Billion
≈ $2.14 Billion USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how ACOTEC SCIEN.H. DL-00001's Asset Resilience Ratio has changed over time. See net assets of ACOTEC SCIEN.H. DL-00001 for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down ACOTEC SCIEN.H. DL-00001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 7W3 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €340.68 Million 18.64%
Total Liquid Assets €340.68 Million 18.64%

Asset Resilience Insights

  • Good Liquidity Position: ACOTEC SCIEN.H. DL-00001 maintains a healthy 18.64% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

ACOTEC SCIEN.H. DL-00001 Industry Peers by Asset Resilience Ratio

Compare ACOTEC SCIEN.H. DL-00001's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 3.37%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
Medical Devices 54.67%
Universus Photo Imagings Limited
NSE:UNIVPHOTO
Medical Devices 30.97%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%
Heramed Ltd
AU:HMD
Medical Devices 0.83%
Acarix A/S
ST:ACARIX
Medical Devices 37.81%

Annual Asset Resilience Ratio for ACOTEC SCIEN.H. DL-00001 (2023–2024)

The table below shows the annual Asset Resilience Ratio data for ACOTEC SCIEN.H. DL-00001.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 6.78% €112.80 Million
≈ $131.88 Million
€1.66 Billion
≈ $1.94 Billion
-8.21pp
2023-12-31 15.00% €241.58 Million
≈ $282.43 Million
€1.61 Billion
≈ $1.88 Billion
--
pp = percentage points

About ACOTEC SCIEN.H. DL-00001

F:7W3 Germany Medical Devices
Market Cap
$377.38 Million
€322.79 Million EUR
Market Cap Rank
#13947 Global
#1406 in Germany
Share Price
€1.03
Change (1 day)
-0.96%
52-Week Range
€0.76 - €1.61
All Time High
€2.26
About

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more